T1	DISO 53 77	problemas de aprendizaje
#1	AnnotatorNotes T1	C0751265; Learning Disabilities; Mental or Behavioral Dysfunction
T2	DISO 81 100	Neurofibromatosis 1
#2	AnnotatorNotes T2	C0027831; Neurofibromatosis 1; Neoplastic Process
T3	CHEM 108 119	lamotrigina
#3	AnnotatorNotes T3	C0064636; lamotrigine; Organic Chemical · Pharmacologic Substance
T4	CHEM 155 166	lamotrigina
#4	AnnotatorNotes T4	C0064636; lamotrigine; Organic Chemical · Pharmacologic Substance
T5	DISO 207 231	neurofibromatosis tipo 1
#5	AnnotatorNotes T5	C0027831; Neurofibromatosis 1; Neoplastic Process
T6	PROC 236 288	estudio de fase II aleatorio, controlado con placebo
T7	PROC 551 594	Consentimiento informado oral y por escrito
#6	AnnotatorNotes T7	C1608381; Consent Mode - Verbal; Health Care Activity (?) + C0811741; Obtain informed written consent; Health Care Activity
T8	DISO 361 385	Neurofibromatosis tipo 1
#7	AnnotatorNotes T8	C0027831; Neurofibromatosis 1; Neoplastic Process
T9	DISO 426 429	NF1
#8	AnnotatorNotes T9	C0027831; Neurofibromatosis 1; Neoplastic Process
T10	PROC 435 446	diagnóstico
#9	AnnotatorNotes T10	C0011900; Diagnosis; Diagnostic Procedure
T11	PROC 46 52	Tratar
#10	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	PROC 475 491	estudio genético
T13	DISO 670 685	NF1 segmentario
#11	AnnotatorNotes T13	C5439205; Segmental neurofibromatosis type 1; Neoplastic Process
T14	DISO 688 712	Problemas graves de oído
#12	AnnotatorNotes T14	C3874334; Severe hearing loss; Finding (?)
T15	PHYS 708 712	oído
#13	AnnotatorNotes T15	C0018767; Hearing; Physiologic Function
T16	CHEM 774 786	medicamentos
#14	AnnotatorNotes T16	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T17	CHEM 788 797	fenitoína
#15	AnnotatorNotes T17	C0031507; phenytoin; Organic Chemical · Pharmacologic Substance
T18	CHEM 799 812	carbamazepina
#16	AnnotatorNotes T18	C0006949; carbamazepine; Organic Chemical · Pharmacologic Substance
T19	CHEM 814 826	fenobarbital
#17	AnnotatorNotes T19	C0031412; phenobarbital; Organic Chemical · Pharmacologic Substance
T20	CHEM 828 837	primidona
#18	AnnotatorNotes T20	C0033148; primidone; Organic Chemical · Pharmacologic Substance
T21	CHEM 839 850	rifampicina
#19	AnnotatorNotes T21	C0035608; rifampin; Antibiotic · Organic Chemical
T22	CHEM 852 862	atazanavir
#20	AnnotatorNotes T22	C1145759; atazanavir; Organic Chemical · Pharmacologic Substance
T23	CHEM 863 872	ritonavir
#21	AnnotatorNotes T23	C0292818; ritonavir; Organic Chemical · Pharmacologic Substance
T24	CHEM 895 908	oxcarbazepina
#22	AnnotatorNotes T24	C0069751; oxcarbazepine; Organic Chemical · Pharmacologic Substance
T25	CHEM 910 920	topiramato
#23	AnnotatorNotes T25	C0076829; topiramate; Organic Chemical · Pharmacologic Substance
T26	CHEM 922 944	píldora anticonceptiva
#24	AnnotatorNotes T26	C0009905; Contraceptives, Oral; Pharmacologic Substance
T27	CHEM 951 960	estrógeno
#25	AnnotatorNotes T27	C0014939; estrogens; Hormone · Organic Chemical · Pharmacologic Substance
T28	CHEM 963 975	progestágeno
#26	AnnotatorNotes T28	C0033306; Progestins; Hormone · Pharmacologic Substance
T29	CHEM 979 994	ácido valproico
#27	AnnotatorNotes T29	C0042291; valproic acid; Organic Chemical · Pharmacologic Substance
T30	CHEM 1043 1054	lamotrigina
#28	AnnotatorNotes T30	C0064636; lamotrigine; Organic Chemical · Pharmacologic Substance
T31	DISO 1058 1078	Reacciones alérgicas
#29	AnnotatorNotes T31	C1527304; Allergic Reaction; Pathologic Function
T32	CHEM 1089 1113	fármacos antiepilépticos
T33	DISO 1143 1152	epilepsia
#30	AnnotatorNotes T33	C0014544; Epilepsy; Disease or Syndrome
T34	DISO 1156 1190	Pensamientos o tendencias suicidas
T35	DISO 1194 1213	Insuficiencia renal
#31	AnnotatorNotes T35	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T36	DISO 1217 1239	Insuficiencia hepática
#32	AnnotatorNotes T36	C0085605; Liver Failure; Disease or Syndrome | C1306571; Hepatic Insufficiency; Pathologic Function
T37	DISO 1255 1269	Tumor cerebral
#33	AnnotatorNotes T37	C0006118; Brain Neoplasms; Neoplastic Process
T38	ANAT 1287 1295	cerebral
#34	AnnotatorNotes T38	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T39	DISO 170 189	déficits cognitivos
#35	AnnotatorNotes T39	C0338656; Impaired cognition; Mental or Behavioral Dysfunction
T40	ANAT 1208 1213	renal
#36	AnnotatorNotes T40	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T41	ANAT 1231 1239	hepática
#37	AnnotatorNotes T41	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T42	ANAT 1261 1269	cerebral
#38	AnnotatorNotes T42	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T43	DISO 1277 1295	patología cerebral
T44	CHEM 874 883	lopinavir
#39	AnnotatorNotes T44	C0674432; lopinavir; Organic Chemical · Pharmacologic Substance
T45	CHEM 884 893	ritonavir
#40	AnnotatorNotes T45	C0292818; ritonavir; Organic Chemical · Pharmacologic Substance
T46	Date 13 17	2013
T47	LIVB 412 421	Pacientes
#41	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	GENE 483 491	genético
#42	AnnotatorNotes T48	C0017337; Genes; Gene or Genome
T49	Age 499 519	entre 12 y 17,5 años
T51	LIVB 602 608	padres
#43	AnnotatorNotes T51	C0015671; Father (person); Family Group | C0030551; parent; Family Group
T52	PHYS 732 737	vista
#44	AnnotatorNotes T52	C0042789; Vision; Organism Function
T53	Form 922 929	píldora
T54	Route 945 949	oral
#45	AnnotatorNotes T54	C1527415; Oral Route of Drug administration; Functional Concept
T55	Duration 1003 1025	los últimos tres meses
T56	PHYS 1156 1168	Pensamientos
#46	AnnotatorNotes T56	C0039869; Thinking, function; Mental Process
T57	PHYS 1243 1251	Embarazo
#47	AnnotatorNotes T57	C0032961; Pregnancy; Organism Function
T59	PHYS 66 77	aprendizaje
#48	AnnotatorNotes T59	C0023185; Learning; Mental Process
T60	PHYS 179 189	cognitivos
#49	AnnotatorNotes T60	C0009240; Cognition; Mental Process
T50	LIVB 628 640	participante
#50	AnnotatorNotes T50	C4554048; Study Participant; Population Group
T58	DISO 715 722	sordera
#51	AnnotatorNotes T58	C0011053; Deafness; Finding
T61	DISO 688 704;726 737	Problemas graves de la vista
#52	AnnotatorNotes T61	C1301509; Severe visual impairment; Disease or Syndrome
T62	DISO 740 747	ceguera
#53	AnnotatorNotes T62	C0456909; Blindness; Disease or Syndrome
A1	Status T30 History_of
A2	Status T31 History_of
A3	Status T33 History_of
#54	AnnotatorNotes T6	C0282460; Phase 2 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#55	AnnotatorNotes T53	C0994475; Pills; Biomedical or Dental Material 
#56	AnnotatorNotes T32	C3537002; Anti-epileptic Agent [EPC]; Pharmacologic Substance (?)
#57	AnnotatorNotes T34	C0424000; Feeling suicidal (finding); Finding 
T63	Spec_cue 1300 1305	pueda
T64	CONC 1306 1313	influir
A4	Assertion T64 Speculated
#58	AnnotatorNotes T64	C0521102; Interferes with; Functional Concept
R3	Used_for Arg1:T3 Arg2:T11	
R4	Overlap Arg1:T39 Arg2:T5	
T65	Observation 142 148	Efecto
#59	AnnotatorNotes T65	C1518681; Outcome of Therapy; Finding (?)
R6	Causes Arg1:T4 Arg2:T65	
R7	Experiences Arg1:T47 Arg2:T9	
R8	Before Arg1:T12 Arg2:T10	
#60	AnnotatorNotes T12	C1273305; Gene studies; Laboratory Procedure
T66	CONC 540 549	inclusión
#61	AnnotatorNotes T66	C1512693; Inclusion; Qualitative Concept
R11	Overlap Arg1:T66 Arg2:T49	
R15	Has_Drug_Form Arg1:T26 Arg2:T53	
R16	Has_Route_or_Mode Arg1:T26 Arg2:T54	
R17	Has_Duration_or_Interval Arg1:T29 Arg2:T55	
R18	Has_Route_or_Mode Arg1:T27 Arg2:T54	
R19	Has_Route_or_Mode Arg1:T28 Arg2:T54	
R20	Has_Drug_Form Arg1:T27 Arg2:T53	
R21	Has_Drug_Form Arg1:T28 Arg2:T53	
R22	Combined_with Arg1:T22 Arg2:T23	
R23	Combined_with Arg1:T44 Arg2:T45	
R24	Has_Duration_or_Interval Arg1:T16 Arg2:T55	
R25	Has_Duration_or_Interval Arg1:T17 Arg2:T55	
R26	Has_Duration_or_Interval Arg1:T18 Arg2:T55	
R27	Has_Duration_or_Interval Arg1:T19 Arg2:T55	
R28	Has_Duration_or_Interval Arg1:T20 Arg2:T55	
R29	Has_Duration_or_Interval Arg1:T21 Arg2:T55	
R30	Has_Duration_or_Interval Arg1:T22 Arg2:T55	
R31	Has_Duration_or_Interval Arg1:T23 Arg2:T55	
R32	Has_Duration_or_Interval Arg1:T44 Arg2:T55	
R33	Has_Duration_or_Interval Arg1:T45 Arg2:T55	
R34	Has_Duration_or_Interval Arg1:T24 Arg2:T55	
R35	Has_Duration_or_Interval Arg1:T25 Arg2:T55	
R36	Has_Duration_or_Interval Arg1:T26 Arg2:T55	
R37	Has_Duration_or_Interval Arg1:T27 Arg2:T55	
R38	Has_Duration_or_Interval Arg1:T28 Arg2:T55	
R39	Causes Arg1:T32 Arg2:T31	
R41	Location_of Arg1:T40 Arg2:T35	
R42	Location_of Arg1:T41 Arg2:T36	
R43	Location_of Arg1:T42 Arg2:T37	
R44	Location_of Arg1:T38 Arg2:T43	
#62	AnnotatorNotes T43	C0006111; Brain Diseases; Disease or Syndrome
R47	Speculation Arg1:T63 Arg2:T64	
R9	Location_of Arg1:T48 Arg2:T12	
R1	Overlap Arg1:T1 Arg2:T2	
R2	Experiences Arg1:T47 Arg2:T12	
A5	Experiencer T47 Patient
A6	Experiencer T51 Family_member
A7	Experiencer T50 Patient
